Nursing Management of Toxicity, Adherence, and Long-Term Care Across First-Line Regimens in EGFR-Mutated Advanced Non–Small Cell Lung Cancer

Panelists discuss the baseline workup nurses and advanced practice providers should complete before the first dose of first-line therapy for epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer (NSCLC).

Panelists discuss how patient education should be timed and reinforced across first-line regimens for epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer (NSCLC).